Concepedia

Author

Luca Bergamaschi

University of BolognaORCID

Also Known As

L B Luca Bergamaschi, L Bergamaschi, L. Bergamaschi, Luca Bergamaschi

165

Publications

2.2K

Citations

26

H-Index

38

Concepts

All Affiliations

University of BolognaAzienda USL di BolognaOnze Lieve Vrouwziekenhuis HospitalFederico II University HospitalUniversity of Campania "Luigi Vanvitelli"
LB

About

Luca Bergamaschi is an author at University of Bologna specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

514

2

Public Health

5

5

168

3

Emergency Medicine

4

4

111

4

Health Sciences

3

3

122

5

Diabetes

3

3

218

Luca Bergamaschi

×

28

Publications

1.7K

Citations

23

H-Index

YearCitations

Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

Pasquale Paolisso, Luca Bergamaschi, Gaetano Santulli,

Cardiovascular Diabetology

2022

204

Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry

Pasquale Paolisso, Luca Bergamaschi, Felice Gragnano,

Pharmacological Research

2022

140

Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients

Raffaele Marfella, Pasquale Paolisso, Celestino Sardu,

Diabetes & Metabolism

2020

135

Hyperglycemia, inflammatory response and infarct size in obstructive acute myocardial infarction and MINOCA

Pasquale Paolisso, Alberto Foà, Luca Bergamaschi,

Cardiovascular Diabetology

2021

121

Impact of admission hyperglycemia on short and long-term prognosis in acute myocardial infarction: MINOCA versus MIOCA

Pasquale Paolisso, Alberto Foà, Luca Bergamaschi,

Cardiovascular Diabetology

2021

119

Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease

Pasquale Paolisso, Luca Bergamaschi, Giulia Saturi,

Frontiers in Pharmacology

2020

85

In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study

Arturo Cesaro, Felice Gragnano, Pasquale Paolisso,

Frontiers in Cardiovascular Medicine

2022

84

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

Pasquale Paolisso, Luca Bergamaschi, Emanuela Concetta D’Angelo,

Frontiers in Pharmacology

2020

75

The value of ECG changes in risk stratification of COVID‐19 patients

Luca Bergamaschi, Emanuela Concetta D’Angelo, Pasquale Paolisso,

Annals of Noninvasive Electrocardiology

2021

73

Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry

Pasquale Paolisso, Luca Bergamaschi, Arturo Cesaro,

Diabetes Research and Clinical Practice

2023

73

Page 1